Solid Biosciences Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $208.2M | $119.1M |
| FY2022 | — | $211.7M | $155.4M |
| FY2023 | — | $126.5M | $74.0M |
| FY2024 | — | $137.2M | $80.2M |
| FY2025 | — | $180.0M | $59.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $208.2M | $119.1M |
| FY2022 | — | $211.7M | $155.4M |
| FY2023 | — | $126.5M | $74.0M |
| FY2024 | — | $137.2M | $80.2M |
| FY2025 | — | $180.0M | $59.9M |